Table.
Racial and Ethnic Distributions of Patients in COVID-19 Outpatient Trials in the United States
| Study author, year of pub-lication | Single or multicenter | White, n/N (%) | Black or African American, n/N (%) | Asian, n/N (%) | American Indian or Alaska Native, n/N (%) | Native Hawaiian or other Pacific Islander, n/N (%) | Hispanic or Latino, n/N (%) |
|---|---|---|---|---|---|---|---|
| Gottlieb,3 2021 | Multi | 507/567 (89.4%) | 33/567 (5.8%) | 19/567 (3.4%) | 3/567 (0.5%) | 1/567 (0.2%) | 245/577 (42.5%) |
| Lenze,4 2020 | Singlea | 106/151 (70.2%) | 38/151 (25.2%) | 4/151 (2.6%) | 1/151 (0.7%) | 0/151 (0.0%) | 5/146 (3.4%) |
| Skipper,5 2020 | Multi | 235/491 (47.9%) | 15/491 (3.1%) | 196/491 (39.9%) | 3/491 (0.6%) | 5/491 (1.0%) | 28/491 (5.7%) |
| Thomas,6 2021 | Multi | 152/205 (74.1%) | 51/205 (24.9%) | NR | NR | NR | NR |
| Weinreich,7 2021 | Multi | 224/264 (84.8%) | 35/264 (13.3%) | 3/264 (1.1%) | 2/264 (0.8%) | NR | NR |
| Median (range) | - | 74.1% (47.9%-89.4%) | 13.3% (3.1%- 25.2%) | 3.0% (1.1%- 39.9%) | 0.7% (0.5%-0.8%) | 0.2% (0.0%- 1.0%) | 5.7% (3.4%- 42.5%) |
NR, not reported.
a
This trial enrolled patients from St Louis, Missouri, only.